Effect of Inflammatory Bowel Disease–Related Characteristics and Treatment Interventions on Cardiovascular Disease Incidence

Roifman, 2011, Chronic inflammatory diseases and cardiovascular risk: a systematic review, Can J Cardiol, 27, 174, 10.1016/j.cjca.2010.12.040 Osterman, 2011, No increased risk of myocardial infarction among patients with ulcerative colitis or Crohn's disease, Clin Gastroenterol Hepatol, 9, 875, 10.1016/j.cgh.2011.06.032 Yayan, 2013, Emerging families of biomarkers for coronary artery disease: inflammatory mediators, Vasc Health Risk Manag, 9, 435, 10.2147/VHRM.S45704 Theocharidou, 2013, Is there an association between inflammatory bowel diseases and carotid Intima-media thickness? Preliminary data, Angiology, 65, 543, 10.1177/0003319713489876 Aloi, 2012, Premature subclinical atherosclerosis in pediatric inflammatory bowel disease, J Pediatr, 161, 10.1016/j.jpeds.2012.03.043 Theocharidou, 2014, Are patients with inflammatory bowel diseases at increased risk for cardiovascular disease?, Clin Gastroenterol Hepatol, 12, 2134, 10.1016/j.cgh.2014.04.004 Kristensen, 2013, Disease activity in inflammatory bowel disease is associated with increased risk of myocardial infarction, stroke and cardiovascular death–a Danish nationwide cohort study, PLoS One, 8, e56944, 10.1371/journal.pone.0056944 Yarur, 2011, Inflammatory bowel disease is associated with an increased incidence of cardiovascular events, Am J Gastroenterol, 106, 741, 10.1038/ajg.2011.63 D'Agostino, 2008, General cardiovascular risk profile for use in primary care: the Framingham Heart Study, Circulation, 117, 743, 10.1161/CIRCULATIONAHA.107.699579 Christodoulidis, 2014, Inflammation in coronary artery disease, Cardiol Rev, 22, 279, 10.1097/CRD.0000000000000006 Yarur, 2011, Predictors of aggressive inflammatory bowel disease, Gastroenterol Hepatol (N Y), 7, 652 Reinecker, 1993, Enhanced secretion of tumour necrosis factor-alpha, IL-6, and IL-1 beta by isolated lamina propria mononuclear cells from patients with ulcerative colitis and Crohn's disease, Clin Exp Immunol, 94, 174, 10.1111/j.1365-2249.1993.tb05997.x Balbay, 2001, Circulating interleukin-1 beta, interleukin-6, tumor necrosis factor-alpha, and soluble ICAM-1 in patients with chronic stable angina and myocardial infarction, Angiology, 52, 109, 10.1177/000331970105200204 Ridker, 2008, Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein, N Engl J Med, 359, 2195, 10.1056/NEJMoa0807646 Cristofaro, 2006, Role of toll-like receptors in infection and immunity: clinical implications, Drugs, 66, 15, 10.2165/00003495-200666010-00002 Levine, 2011, Autophagy in immunity and inflammation, Nature, 469, 323, 10.1038/nature09782 Di Micco, 2009, Intima-media thickness evolution after treatment with infliximab in patients with rheumatoid arthritis, Int J Gen Med, 2, 141, 10.2147/IJGM.S5178 Jain, 2013, Harms of TNF inhibitors in rheumatic diseases: a focused review of the literature, Immunotherapy, 5, 265, 10.2217/imt.13.10 Curtis, 2007, Heart failure among younger rheumatoid arthritis and Crohn's patients exposed to TNF-alpha antagonists, Rheumatology (Oxford), 46, 1688, 10.1093/rheumatology/kem212 Angel, 2010, Tumor necrosis factor-alpha antagonists improve aortic stiffness in patients with inflammatory arthropathies: a controlled study, Hypertension, 55, 333, 10.1161/HYPERTENSIONAHA.109.143982 Brånén, 2004, Inhibition of tumor necrosis factor-alpha reduces atherosclerosis in apolipoprotein E knockout mice, Arterioscler Thromb Vasc Biol, 24, 2137, 10.1161/01.ATV.0000143933.20616.1b Panteris, 2006, Acute coronary syndrome after infliximab therapy in a patient with Crohn's disease, World J Gastroenterol, 12, 6235, 10.3748/wjg.v12.i38.6235 Heeneman, 2007, Drug-induced immunomodulation to affect the development and progression of atherosclerosis: a new opportunity?, Expert Rev Cardiovasc Ther, 5, 345, 10.1586/14779072.5.2.345 Louis, 2014, Use of azathioprine in IBD: modern aspects of an old drug, Gut, 63, 1695, 10.1136/gutjnl-2013-306711 Atreya, 2008, Azathioprine in inflammatory bowel disease: improved molecular insights and resulting clinical implications, Expert Rev Gastroenterol Hepatol, 2, 23, 10.1586/17474124.2.1.23 Dongarrà, 2013, Clinical drug response to thiopurines is associated to a lower interferon-γ production by IBD patient's T lymphocytes, J Crohns Colitis, 7, e497, 10.1016/j.crohns.2013.04.017 Liuzzo, 2000, Monoclonal t-cell proliferation and plaque instability in acute coronary syndromes, Circulation, 101, 2883, 10.1161/01.CIR.101.25.2883